These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 6152328)

  • 1. Cardiovascular effects of dynorphin A-(1-8), dynorphin A-(1-13) and dynorphin A-(1-17) microinjected into the preoptic medialis nucleus of the rat.
    Feuerstein G; Faden AI
    Neuropeptides; 1984 Dec; 5(1-3):295-8. PubMed ID: 6152328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dynorphin A (1-13), microinjected into the preoptic area, stimulates water intake in rats.
    Shimizu H; Shimomura Y; Negishi M; Kobayashi I; Kobayashi S
    Life Sci; 1989; 45(1):25-30. PubMed ID: 2568571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intrathecal administration of dynorphin A and its fragments increase heart rate and arterial pressure in the urethane anesthetized rat: mediation by a nonopioid mechanism.
    Rochford J; Godin C; Henry JL
    Brain Res; 1991 Nov; 565(1):67-77. PubMed ID: 1685349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Morphine and dynorphin(1-13) microinjected into the medial preoptic area and nucleus accumbens: effects on sexual behavior in male rats.
    Band LC; Hull EM
    Brain Res; 1990 Jul; 524(1):77-84. PubMed ID: 1976031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microinjection of dynorphin into the supraoptic and paraventricular nuclei produces antidiuretic effects through vasopressin release.
    Tsushima H; Mori M; Matsuda T
    Jpn J Pharmacol; 1993 Dec; 63(4):461-8. PubMed ID: 7907154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dynorphin-related peptides cause motor dysfunction in the rat through a non-opiate action.
    Faden AI; Jacobs TP
    Br J Pharmacol; 1984 Feb; 81(2):271-6. PubMed ID: 6142741
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Both dynorphin A(1-17) and [Des-Tyr1]dynorphin A(2-17) inhibit adenylyl cyclase activity in rat caudate putamen.
    Claye LH; Unterwald EM; Ho A; Kreek MJ
    J Pharmacol Exp Ther; 1996 Apr; 277(1):359-65. PubMed ID: 8613942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opiate and alpha receptor antagonists block the pressor responses of conscious rats given intravenous dynorphin.
    Thornhill JA; Gregor L; Saunders WS
    Peptides; 1989; 10(1):171-7. PubMed ID: 2568623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dynorphin(1-8) immunoreactivity in brainstem and hypothalamic nuclei of normotensive and age-matched hypertensive rat strains.
    Conway EL; Maccarrone C; Verberne AJ; Louis WJ
    Clin Exp Hypertens A; 1987; 9(1):109-24. PubMed ID: 2884055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distribution of immunoreactive dynorphin A1-8 in discrete nuclei of the rat brain: comparison with dynorphin A.
    Zamir N; Palkovits M; Brownstein MJ
    Brain Res; 1984 Jul; 307(1-2):61-8. PubMed ID: 6147178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intrathecal dynorphin A1-13 and dynorphin A3-13 reduce rat spinal cord blood flow by non-opioid mechanisms.
    Long JB; Kinney RC; Malcolm DS; Graeber GM; Holaday JW
    Brain Res; 1987 Dec; 436(2):374-9. PubMed ID: 2893653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential cardiovascular effects of mu, delta and kappa opiate agonists at discrete hypothalamic sites in the anesthetized rat.
    Feuerstein G; Faden AI
    Life Sci; 1982 Nov 15-22; 31(20-21):2197-200. PubMed ID: 6131355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opioid and nonopioid mechanisms may contribute to dynorphin's pathophysiological actions in spinal cord injury.
    Faden AI
    Ann Neurol; 1990 Jan; 27(1):67-74. PubMed ID: 1967925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distribution of opioid peptides in the preoptic region: immunohistochemical evidence for a steroid-sensitive enkephalin sexual dimorphism.
    Simerly RB; McCall LD; Watson SJ
    J Comp Neurol; 1988 Oct; 276(3):442-59. PubMed ID: 2903870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Colocalization of progesterone receptors in parvicellular dynorphin neurons of the ovine preoptic area and hypothalamus.
    Foradori CD; Coolen LM; Fitzgerald ME; Skinner DC; Goodman RL; Lehman MN
    Endocrinology; 2002 Nov; 143(11):4366-74. PubMed ID: 12399433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dynorphins other than dynorphin A(1-17) lack spinal antianalgesic activity but do act on dynorphin A(1-17) receptors.
    Rady JJ; Fujimoto JM; Tseng LF
    J Pharmacol Exp Ther; 1991 Dec; 259(3):1073-80. PubMed ID: 1684812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurological dysfunction after intrathecal injection of dynorphin A (1-13) in the rat. II. Nonopioid mechanisms mediate loss of motor, sensory and autonomic function.
    Long JB; Petras JM; Mobley WC; Holaday JW
    J Pharmacol Exp Ther; 1988 Sep; 246(3):1167-74. PubMed ID: 2901487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Receptors mediating depressor responses to intrahippocampal injection of L-glutamate and dynorphin-A(1-8) in conscious, spontaneously hypertensive and normotensive Wistar-Kyoto rats.
    Wang JQ; Ingenito AJ
    J Cardiovasc Pharmacol; 1994 Dec; 24(6):999-1003. PubMed ID: 7898086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intrastriatal injections of dynorphin A fragments potentiate the dorsal immobility response in rats.
    Meyer ME
    Pharmacol Biochem Behav; 1993 Feb; 44(2):329-32. PubMed ID: 8095341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of discrete brain lesions on hypothalamic and pituitary immunoreactive dynorphin.
    Spampinato S; Stanzani S; Ferri S
    Neurosci Lett; 1986 Mar; 65(1):109-13. PubMed ID: 2871529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.